Serrao M, Cardinali P, Rossi P, Parisi L, Tramutoli R, Pierelli F
Istituto di Clinica delle Malattie Nervose e Mentali, Università La Sapienza, Roma, Rome, Italy.
Acta Neurol Scand. 1998 Dec;98(6):458-60. doi: 10.1111/j.1600-0404.1998.tb07330.x.
We report a case of "myokymia-cramp syndrome", a rare and benign disease consisting of muscular cramps in the upper and lower limbs associated with generalized myokymias. In our patient, cramps had been present since adolescence and had increased in frequency and duration during the last 3 years, occurring about 8 or 9 times a day. Cramps were mainly nocturnal and also precipitated by walking; a previous treatment with carbamazepine did not improve the symptoms. Gabapentin therapy proved to be very satisfactory in relieving muscular cramps with a relatively low dosage (600 mg/day) and without any remarkable side effects. The possible interpretation of the mechanism involved in gabapentin induced relief of cramps is discussed. Gabapentin should be considered as a safe alternative treatment for muscular cramps.
我们报告一例“肌束颤搐-痉挛综合征”,这是一种罕见的良性疾病,表现为上下肢肌肉痉挛并伴有全身性肌束颤搐。在我们的患者中,痉挛自青春期起就存在,在过去3年中发作频率和持续时间增加,每天发作约8或9次。痉挛主要在夜间发作,步行也会诱发;先前使用卡马西平治疗未能改善症状。加巴喷丁治疗以相对低剂量(600毫克/天)缓解肌肉痉挛且无任何明显副作用,效果非常令人满意。文中讨论了加巴喷丁缓解痉挛所涉及机制的可能解释。加巴喷丁应被视为治疗肌肉痉挛的一种安全替代疗法。